No BRCA1 germline mutation in a family with uterine papillary serous carcinoma: A case report

European Journal of Gynaecological Oncology

Volumn 22, Issue 5, 2001, Pages 336-338

  Pejovic, T ^a   Koul, A ^a   Olsen, D ^a   Chambers, J T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Immunocytochemistry; Uterine papillary serous carcinoma

Indexed keywords

TOPOTECAN;

ADULT; AGED; CANCER INCIDENCE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GERM LINE; HUMAN; IMMUNOCYTOCHEMISTRY; JEW; METHYLATION; ONCOGENE; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; TREATMENT OUTCOME; UTERUS CARCINOMA;

AGED; CYSTADENOCARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; UTERINE NEOPLASMS;

EID: 0035210054     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma
2. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma
3. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature
4. BRCA1 germline mutations in women with uterine serous papillary carcinoma
5. Is uterine serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
6. Moderate frequency of BRCA1 and BRCA2 gem-line mutations in Scandinavian familial breast cancer
7. Rapid detection of translating-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test
8. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
9. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis
10. Frequency of germline and somatic BRCA1 mutations in ovarian cancer
11. Reduction of BRCA1 expression in sporadic ovarian cancer
12. BRCA1 promoter region hypermethylation in ovarian carcinoma: A population based study